Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors
暂无分享,去创建一个
M. Dimopoulos | I. Trougakos | K. Koutsoukos | A. Sklirou | E. Terpos | A. Briasoulis | M. Liontos | F. Zagouri | C. Markellos | Eleni-Dimitra Papanagnou